Clinical trial · Observational
Impact of the Coronavirus (COVID-19) on Patients With Cancer
NCT04330521CI-TRIAL-00109531recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to understand the impact of COVID-19 on patients with cancer through a survey.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| COVID-19 | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Number of participants who fill out the survey and participate in the semi-structured interviews.
- timeFrame
- 12 Months
- description
- We will track the number of participants who fill out the survey for the 12 month duration of the study and the number of participants who participate in the semi-structured telephone interviews.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 99 Years
Show eligibility criteria text
Inclusion Criteria: 1. The patients must be 18 years or older. 2. Patients who opt in to complete the survey. 3. Patients must have the capacity to verbally consent for the interview. Exclusion Criteria: 1.Patients who under the age of 18 years old.
References
Publications (0)
Data not yet available
No reference posted for this study.